Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.

Wright-Hughes A, Ford AC, Alderson SL, Ow PL, Ridd MJ, Foy R, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Newman S, Taylor CA, Teasdale EJ, Thornton R, Everitt HA, Farrin AJ

Open source

DOI: 10.3310/bfcr7986
Published: 2024 Oct
Container: Health technology assessment (Winchester, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3310/bfcr7986,
  title = {Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.},
  author = {Wright-Hughes A and Ford AC and Alderson SL and Ow PL and Ridd MJ and Foy R and Bishop FL and Chaddock M and Cook H and Cooper D and Fernandez C and Guthrie EA and Hartley S and Herbert A and Howdon D and Muir DP and Newman S and Taylor CA and Teasdale EJ and Thornton R and Everitt HA and Farrin AJ},
  year = {2024},
  journal = {Health technology assessment (Winchester, England)},
  doi = {10.3310/bfcr7986},
  url = {https://doi.org/10.3310/bfcr7986}
}

RIS

TY  - JOUR
TI  - Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.
AU  - Wright-Hughes A
AU  - Ford AC
AU  - Alderson SL
AU  - Ow PL
AU  - Ridd MJ
AU  - Foy R
AU  - Bishop FL
AU  - Chaddock M
AU  - Cook H
AU  - Cooper D
AU  - Fernandez C
AU  - Guthrie EA
AU  - Hartley S
AU  - Herbert A
AU  - Howdon D
AU  - Muir DP
AU  - Newman S
AU  - Taylor CA
AU  - Teasdale EJ
AU  - Thornton R
AU  - Everitt HA
AU  - Farrin AJ
PY  - 2024
JO  - Health technology assessment (Winchester, England)
DO  - 10.3310/bfcr7986
UR  - https://doi.org/10.3310/bfcr7986
ER  -

APA

A, W., AC, F., SL, A., PL, O., MJ, R., R, F., FL, B., M, C., H, C., D, C., C, F., EA, G., S, H., A, H., D, H., DP, M., S, N., CA, T., EJ, T., R, T., HA, E., & AJ, F. (2024). Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.. Health technology assessment (Winchester, England). https://doi.org/10.3310/bfcr7986

Source records

pubmed · retrieved 2026-09-25T04:03:04.534Z